Literature DB >> 30321632

On the structure-function of MHC class II molecules and how single amino acid polymorphisms could alter intracellular trafficking.

Jacques Thibodeau1, Mohamed Abdelwafi Moulefera2, Renaud Balthazard2.   

Abstract

Classical HLA class II molecules are highly polymorphic heterodimeric transmembrane proteins encoded by a polygenic cluster on chromosome 6. Polymorphic residues in the membrane-distal domains ensure that a large collection of microbial peptides can be bound in the human population. Still, the HLA-DR, -DP and -DQ isotypes show a high degree of conservation in their overall tertiary and quaternary structures, in line with their common function in T cell receptor activation. Interestingly, the primary structure of the intracellular domains are highly divergent between isotypes and they also show allotypic variations. The functional impact of these differences remains to be fully appreciated. Here, we address the role of the MHC class II cytoplasmic tails in intracellular trafficking. First, the emphasis will be on the interplay between the cytoplasmic domains of classical human MHC class II molecules and those of the invariant chain chaperone (CD74) isoforms. Then, we will examine the importance of the highly conserved β-chain cytoplasmic lysine residue in the ubiquitin-driven trafficking of MHC class II molecules. These considerations should help understand the potential functional impact of sequence variations that may arise in the cytoplasmic tails and transmembrane domains of MHC class II molecules.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Antigen presentation; CD74; Di-arginine; Endoplasmic reticulum; Iip35; Invariant chain; MARCH1; MHC class II molecules; Polymorphism; Ubiquitin

Mesh:

Substances:

Year:  2018        PMID: 30321632     DOI: 10.1016/j.humimm.2018.10.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  1 in total

1.  Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cells.

Authors:  A Casasola-LaMacchia; M S Ritorto; R J Seward; N Ahyi-Amendah; A Ciarla; T P Hickling; H Neubert
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.